Improving Your Survival – Find the Right Hospital

Today’s New York Times (8/23/16) had an article written by Austin Frakt, which should be of interest to all of us with prostate cancer. The article, “Why It’s Crucial to Choose the Right Hospital appeared on page A3. The entire article is best described by the first sentence, “There’s an exceeding simple way to get [...]

Hyperbaric Oxygen Therapy Treats Prostate Cancer Radiation Induced Hematuria

Post-radiation hematuria (PRH), or blood clots in the urine sometimes accompanied with bladder pain or pain in the back, has been a common side effect of radiation delivered to the pelvis. This type of radiation treatment is common as a primary prostate cancer treatment as well as for men who have a prostate cancer recurrence [...]

Is Alkaline Phosphatase A Bio-Marker To Predict PSA Decline And Clinical Benefit From Abiraterone Acetate in Bone Metastatic Castration Resistant Prostate Cancer

Again and again I have mentioned the huge need we have for the development of reliable bio-markers. Reliable bio-markers will allow us to know which men will respond positively to a treatment (also those who will not) and when a treatment is still effective (also when it no longer is effective). These biomarkers really don’t [...]

Some Factors That Might Be Predictors of the Duration of Abiraterone Acetate in Men with Castration-Resistant Prostate Cancer

Being able to make better decisions about drug sequencing and combinations has become one of the current hot topics in prostate cancer research. Given that we have a number of newer drugs to use this is an important clinical issue as we make important treatment decisions. Making these clinical decisions is tough.  The fact is [...]

Penile Implants – The Options, The Pros and the Cons of the Different Designs

There are a few things you should know about penile implants if you are considering having one to treat your erectile dysfunction. First you should know that there are actually two different types of implants available, inflatable implants and semi-rigid rods.  The inflatable implants have two different design options; they come in either a two- [...]

CVS Removes Xtandi From Its Formulary List – They Will Not Pay!

CVS Health, a major retail pharmaceutical insurer and supplier has raised some consternation and concerns and it should also raise yours. Last Tuesday, CVS rolled out their 2017 formulary list that left off the some of the world’s top-selling drugs including a vital castrate resistant prostate cancer drug. The pharmacy benefits manager removed from their [...]

Flawed Study Shows A Sharp Rise in Advanced Prostate Cancer

Yesterday’s post described research performed at Northwestern University that found a sharp increase in the number of men diagnosed with advanced aggressive prostate cancer between 2004 and 2013. The research interpretation raised the possibility that the United States Preventive Task Force (USPTF) decision to recommend against the use of the PSA test for prostate cancer [...]

Reporting A Concerning Increase In The Number Of Men Diagnosed With Advanced Prostate Cancer

According to information from a published report from the Tuesday, July 19, 2016 edition of HealthDay News, there has been an explosion of new cases of advanced prostate cancer in the United States. They reported on a study using data on nearly 800,000 men listed in the National Cancer Data Base who had been diagnosed [...]

Go to Top